Skip to content
International Academy for Clinical Hematology (IACH) Logo
  • About
    • Bylaws
    • Membership
    • Founders
    • Mission
    • Topics
    • Journal
    • IACH Supporters
    • Contact
  • Meetings
    • World Congresses on Controversies in Multiple Myeloma (COMy)
    • Annual Meeting of the International Academy for Clinical Hematology
    • International Summit on Immunotherapy and Cellular Therapy in Cancer (ICTC)
  • Webinars
  • Post-Cong. webinars
  • Special webinars
  • Shoulders of Giants
  • Journal Club
  • IACH News

Dr. Eolia Brissot – Approval of maribvir for post-transplant cytomegalovirus infection

Home/All/Dr. Eolia Brissot – Approval of maribvir for post-transplant cytomegalovirus infection
Previous Next

Dr. Eolia Brissot – Approval of maribvir for post-transplant cytomegalovirus infection

By Amnon Ron|2022-03-27T20:51:22+00:00March 27th, 2022|All|Comments Off on Dr. Eolia Brissot – Approval of maribvir for post-transplant cytomegalovirus infection

Share This Story, Choose Your Platform!

FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkEmail

About the Author: Amnon Ron

Related Posts

  • Prof. Mohamad Mohty – New treatments for refractrory acute GVHD

    Prof. Mohamad Mohty – New treatments for refractrory acute GVHD

  • Prof. Sebastian Giebel – CAR T cells for adult ALL

    Prof. Sebastian Giebel – CAR T cells for adult ALL

  • Prof. Farhad Ravandi – MRD in AML

    Prof. Farhad Ravandi – MRD in AML

  • Prof. Iskra Pusic – Recent updated in Acute GVHD

    Prof. Iskra Pusic – Recent updated in Acute GVHD

  • Prof. Arnon Kater -State of the art therapy in CLL

    Prof. Arnon Kater -State of the art therapy in CLL

About

The IACH is founded by an international group of physicians whose focus is to promote good clinical practice in the field of clinical hematology.

Contact

info@clinical-hematology.org
+44 203 291 1603

Copyright © 2021 International Academy for Clinical Hematology | All Rights Reserved

Page load link
Go to Top